Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Bicycle Therapeutics plc (BCYC)

96 + Investors. Track Smart Money conviction in BCYC. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -13
Streak
1Q ▼
Buyers last Q
57%

Smart Money Signals — BCYC

Based on 97 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their BCYC positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
📊

High ownership — 87% of 3.0Y peak

87% of all-time peak
97 funds currently hold this stock — 87% of the 3.0-year high of 111 funds (reached 2025 Q2). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
📶

Steady growth — +4% more funds vs a year ago

fund count last 6Q
+4 new funds entered over the past year (+4% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟡

Slight buying edge — 57% buying

59 buying45 selling
Last quarter: 59 funds bought or added vs 45 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
⚠️

Fewer new buyers each quarter (-7 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 31 → 9 → 23 → 16. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

40% of holders stayed for 2+ years

■ 40% conviction (2yr+) ■ 39% medium ■ 21% new
39 out of 97 hedge funds have held BCYC for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares -4%, value -41%

Value
-40%
Shares
-4%
Last quarter: funds added -4% more shares while total portfolio value only changed -41%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
➡️

Steady discovery — ~16 new funds/quarter

14 → 31 → 9 → 23 → 16 new funds/Q
New funds entering each quarter: 31 → 9 → 23 → 16. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Veteran-anchored — 56% veterans vs 25% newcomers

■ 56% veterans ■ 20% 1-2yr ■ 25% new
Entry-cohort mix of 102 holders: 57 (56%) are 2+ year veterans, 20 entered 1–2 years ago, and 25 (25%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
📋

Smaller funds dominant — 12% AUM from top-100

12% from top-100 AUM funds
24 of 97 holders rank in the top 100 by AUM, but together hold only 12% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
2.9
out of 10
Low Exit Risk
Exit risk score 2.9/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — BCYC

In 2026 Q1, 59 hedge funds were net buyers of BCYC (16 opened a new position, 43 added to an existing one), while 45 reduced or exited (16 trimmed, 29 sold completely) — a 57% buyer ratio, indicating a slight buying edge. Net fund flow last quarter: -13 funds (more exits than new entries). Total institutional holders: 97.

Hedge Fund Ownership: BCYC

How many hedge funds hold BCYC — quarterly history vs. share price
Quarterly hedge fund ownership of BCYC vs. share price

Market Analysis: BCYC

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: BCYC

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Bicycle Therapeutics plc (BCYC) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much BCYC has moved relative to its sector benchmark (XLV) since the 2026 Q2 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End June 30, 2026 · 47d ago
BCYC
-8.0%
XLV
+5.5%

BCYC outperformed XLV by -13.5% since June 30, 2026.

Since 13F Filing Date August 14, 2026 · 2d ago
BCYC
+0.0%
XLV
+0.0%

Since the filing became public, BCYC outperformed XLV by +0.0% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

6 top-rated funds 1 high-conviction
Consensus
3.7
/ 10
breadth
×
Elite
1.4
/ 10
conviction
Hedge Fund Positioning: BCYC
2026 Q2 Stats Unlock in 3 days 96 + Investors

Track Smart Money conviction in BCYC. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 96 110 -12.73%
13F Shares 38M 40M -4.49%
Total Value $162M $272M -40.55%
New Positions 15 23 -8
Increased Positions 42 35 +7
Closed Positions 29 13 +16
Reduced Positions 15 29 -14
Total Calls 2 4 -50.0%
Total Puts 3 3 -
PUT/CALL Ratio 1.5 0.75 Bearish

Statistics: BCYC

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

96 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in BCYC. Verified SEC 13F-HR filings.

QUARTER:
2026 Q2 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.
Top 25 BCYC holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Fcpm III Services B.V. 1.96% 3,468,430 $14.7M
2 Peapod Lane Capital LLC 1.54% 537,978 $2.3M
3 GSK plc 1.08% 1,529,561 $6.5M
4 Rangeley Capital, LLC 0.98% 253,500 $1.1M
5 Flax Pond Capital, LLC 0.72% 196,136 $910K
6 Birchview Capital, LP 0.62% 313,616 $1.3M
7 Long Focus Capital Management, LLC 0.36% 3,310,687 $14.0M
8 Nano Cap New Millennium Growth Fund L P 0.26% 80,000 $339K
9 Diadema Partners LP 0.25% 462,724 $2.0M
10 Baker BROS. Advisors LP 0.23% 10,885,357 $46.2M
11 Verdad Advisers, LP 0.21% 51,100 $217K
12 Armistice Capital, LLC 0.18% 3,398,000 $14.4M
13 Persistent Asset Partners Ltd 0.15% 117,254 $497K
14 Forefront Analytics, LLC 0.10% 21,822 $93K
15 Virtus Investment Advisers, LLC 0.08% 80,789 $343K
16 DAFNA Capital Management LLC 0.05% 64,492 $273K
17 Eversept Partners, LP 0.04% 190,715 $809K
18 Marquette Asset Management, LLC 0.04% 72,854 $309K
19 Aigen Investment Management, LP 0.02% 19,319 $82K
20 Portland Investment Counsel INC. 0.02% 15,000 $64K
21 Moore Capital Management, LP 0.02% 275,000 $1.2M
22 Axq Capital, LP 0.01% 27,368 $116K
23 Woodstock Corp 0.01% 29,146 $124K
24 ADAR1 Capital Management, LLC 0.01% 50,638 $215K
25 Renaissance Technologies LLC 0.01% 1,533,400 $6.5M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Bicycle Therapeutics plc (BCYC)

What does the Smart Money Trend signal show for BCYC?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their BCYC positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for BCYC?

Slight buying edge — 57% buying: Last quarter: 59 funds bought or added vs 45 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for BCYC holders?

Smaller funds dominant — 12% AUM from top-100: 24 of 97 holders rank in the top 100 by AUM, but together hold only 12% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held BCYC?

40% of holders stayed for 2+ years: 39 out of 97 hedge funds have held BCYC for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Bicycle Therapeutics plc (BCYC) following the 2026 Q2 hedge fund 13F filings?

As of today, BCYC has moved +0.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (June 30, 2026), BCYC has gained -8.0% vs +5.5% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →